Showing results (191-200 of 367) with videos related to
Sort By:
Pageof 37
Heart Rhythm|April 8, 2017
Characterization of health care utilization in patients receiving implantable cardioverter-defibrillator therapies: An analysis of the managed ventricular pacing trialJohn Rickard, David Whellen, Lou Sherfesee, et al.JACC. Clinical Electrophysiology|May 16, 2018
Interventricular Electrical Delay Is Predictive of Response to Cardiac Resynchronization TherapyMichael R Gold, Jagmeet P Singh, Kenneth A Ellenbogen, et al.Heart Rhythm|October 27, 2015
Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation: A multicenter experienceEric Buch, Michael Share, Roderick Tung, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 23, 2023
Institutional experience report on the target contouring workflow in the radiotherapy department for stereotactic arrhythmia radioablation delivered on conventional linear acceleratorsMihaela Rosu-Bubulac, Cory R Trankle, Pranav Mankad, et al.Journal of Cardiovascular Electrophysiology|June 4, 2004
Ablation of superior pulmonary veins compared to ablation of all four pulmonary veins:Demosthenes G Katritsis, Kenneth A Ellenbogen, Demosthenes B Panagiotakos, et al.Pacing and Clinical Electrophysiology : PACE|January 24, 2007
Activation sequence modification during cardiac resynchronization by manipulation of left ventricular epicardial pacing stimulus strengthUsha B Tedrow, William G Stevenson, Mark A Wood, et al.Heart Rhythm|March 5, 2013
Diagnosis of high-voltage conductor fractures in Sprint Fidelis leadsJayanthi N Koneru, Bruce D Gunderson, Haresh Sachanandani, et al.Heart Rhythm|December 24, 2017
Permanent His-bundle pacing: Long-term lead performance and clinical outcomesPugazhendhi Vijayaraman, Angela Naperkowski, Faiz A Subzposh, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 2, 2015
A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakersMichael D Ezekowitz, Kenneth A Ellenbogen, John P DiMarco, et al.Pacing and Clinical Electrophysiology : PACE|May 15, 2018
Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leadsCory R Trankle, Zachary M Gertz, Jayanthi N Koneru, et al.Pageof 37